Tag: Retinitis

Cmvee 450 mg, containing the antiviral agent valganciclovir, is prescribed for serious viral infections, particularly those caused by cytomegalovirus (CMV). It is used for specific patient populations, including adults with AIDS who have CMV retinitis and organ transplant recipients to prevent CMV disease.

First approved by the FDA in 2001, valganciclovir is a highly effective antiviral drug that serves as a prodrug for ganciclovir and is used to treat and prevent cytomegalovirus (CMV) infections. This oral medication offers a convenient alternative to intravenous ganciclovir for controlling CMV-related illnesses, especially in immunocompromised patients.